Topic

Tegsedi (inotersen)

A collection of 33 issues

How to Get Tegsedi (Inotersen) Covered by Cigna in Washington: Complete Prior Authorization and Appeals Guide

Quick Answer: Getting Tegsedi (Inotersen) Approved by Cigna in Washington Cigna requires prior authorization for Tegsedi (inotersen) with strict criteria: confirmed hATTR polyneuropathy, TTR gene mutation, REMS enrollment, and detailed lab monitoring plan. In Washington, you have 72 hours for standard PA decisions and strong appeal rights including independent external

How to Get Tegsedi (inotersen) Covered by Aetna (CVS Health) in Washington: Complete Prior Authorization Guide

Answer Box: Getting Tegsedi (inotersen) Covered by Aetna (CVS Health) in Washington Aetna (CVS Health) requires prior authorization for Tegsedi (inotersen) with specific documentation: TTR gene mutation testing, specialist prescription, and FDA REMS enrollment. Submit via Availity portal or fax (866-752-7021) at least 2 weeks before treatment. If denied, Washington

How to Get Tegsedi (Inotersen) Covered by Cigna in Georgia: Complete Prior Authorization and Appeals Guide

Quick Answer: To get Tegsedi (inotersen) covered by Cigna in Georgia, you need: (1) genetic confirmation of hATTR polyneuropathy, (2) REMS enrollment for prescriber and patient, (3) prior authorization with baseline labs and monitoring plan, and (4) specialty pharmacy routing through Accredo. If denied, Georgia law gives you 60 days

How to Get Tegsedi (inotersen) Covered by Cigna in Michigan: Complete Prior Authorization and Appeals Guide

Answer Box: Getting Tegsedi (inotersen) Covered by Cigna in Michigan Tegsedi (inotersen) for hATTR polyneuropathy requires prior authorization from Cigna through Express Scripts, REMS program enrollment, and specialty pharmacy dispensing via Accredo. Michigan patients have strong appeal rights through DIFS external review (127 days to file after final denial). Start

Coding That Helps Get Tegsedi (inotersen) Approved by Cigna in Florida: ICD-10, HCPCS/J-Code, and NDC Guide

Answer Box: Getting Tegsedi (inotersen) Coded Correctly for Cigna Coverage in Florida Fastest path to approval: Use ICD-10 code E85.1 (neuropathic heredofamilial amyloidosis), HCPCS J3490 (unclassified drugs) with NDC 72126-0007-02, and submit via Cigna's electronic PA system through Express Scripts/Accredo. Tegsedi requires prior authorization under the

How to Get Tegsedi (Inotersen) Covered by Aetna CVS Health in Illinois: Complete Prior Authorization and Appeals Guide

Answer Box: Getting Tegsedi (Inotersen) Covered by Aetna CVS Health in Illinois Tegsedi (inotersen) requires prior authorization from Aetna CVS Health for hATTR polyneuropathy coverage in Illinois. Key requirements: confirmed TTR gene mutation, documented polyneuropathy symptoms, specialist prescription (neurologist/geneticist), and REMS program enrollment. Submit via Aetna provider portal with

How to Get Tegsedi (inotersen) Covered by UnitedHealthcare in Florida: Complete Prior Authorization and Appeals Guide

Answer Box: Getting Tegsedi (inotersen) Approved by UnitedHealthcare in Florida UnitedHealthcare requires prior authorization for Tegsedi (inotersen) with strict criteria: confirmed hATTR polyneuropathy (ICD-10 E85.1), pathogenic TTR mutation, neurologist involvement, and REMS enrollment. No step therapy required, but baseline labs and monitoring plan are mandatory. First step: Gather genetic

How to Get Tegsedi (inotersen) Covered by UnitedHealthcare in Texas: Complete Prior Authorization Guide with Forms and Appeals

Answer Box: Getting Tegsedi (inotersen) Approved by UnitedHealthcare in Texas Quick Path to Coverage: UnitedHealthcare requires prior authorization for Tegsedi (inotersen) for hereditary transthyretin amyloidosis with polyneuropathy. You'll need: (1) confirmed hATTR diagnosis with TTR mutation, (2) REMS program enrollment for patient, prescriber, and pharmacy, and (3) baseline

How to Get Tegsedi (Inotersen) Covered by Blue Cross Blue Shield in New Jersey: Complete Prior Authorization and Appeal Guide

Quick Answer: Getting Tegsedi Covered by Blue Cross Blue Shield in New Jersey Tegsedi (inotersen) requires prior authorization from Blue Cross Blue Shield plans in New Jersey, typically as a non-preferred specialty drug. To get coverage: (1) Your neurologist submits a PA request with hATTR polyneuropathy diagnosis, genetic testing, and

Work With Your Doctor to Get Tegsedi (inotersen) Covered by Blue Cross Blue Shield in New York: Complete Prior Authorization and Appeals Guide

Answer Box: Getting Tegsedi Covered by Blue Cross Blue Shield in New York Eligibility: Tegsedi (inotersen) requires prior authorization from Blue Cross Blue Shield for hATTR polyneuropathy in adults. You must be enrolled in the REMS program with regular lab monitoring. Fastest Path: Work with your neurologist to submit complete